180 related articles for article (PubMed ID: 26332059)
1. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association.
Kanayama HO; Fukumori T; Fujimoto H; Nakanishi H; Ohyama C; Suzuki K; Nishiyama H; Eto M; Miki T; Kamoi K; Kubota Y; Takahashi S; Homma Y; Naito S
Int J Urol; 2015 Sep; 22(9):S1-7. PubMed ID: 26332059
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and oncological outcomes of testicular cancer patients registered in 2005 and 2008: the first large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Miki T; Kamoi K; Fujimoto H; Kanayama HO; Ohyama C; Suzuki K; Nishiyama H; Eto M; Naito S; Fukumori T; Kubota Y; Takahashi S; Mikami K; Homma Y
Int J Urol; 2014 Aug; 21(8):S1-6. PubMed ID: 24725194
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes of renal pelvic and ureteral cancer patients registered in 2005: the first large population report from the Cancer Registration Committee of the Japanese Urological Association.
Fujimoto H; Nakanishi H; Miki T; Kanayama HO; Ohyama C; Suzuki K; Nishiyama H; Eto M; Naito S; Fukumori T; Kubota Y; Takahashi S; Homma Y; Kamoi K
Int J Urol; 2014 May; 21(5):527-34. PubMed ID: 24372688
[TBL] [Abstract][Full Text] [Related]
4. Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era.
Pal SK; Nelson RA; Vogelzang N
PLoS One; 2013; 8(5):e63341. PubMed ID: 23658823
[TBL] [Abstract][Full Text] [Related]
5. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
6. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
Keskin SK; Msaouel P; Hess KR; Yu KJ; Matin SF; Sircar K; Tamboli P; Jonasch E; Wood CG; Karam JA; Tannir NM
J Urol; 2017 Sep; 198(3):530-537. PubMed ID: 28411072
[TBL] [Abstract][Full Text] [Related]
8. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.
Gupta R; Billis A; Shah RB; Moch H; Osunkoya AO; Jochum W; Hes O; Bacchi CE; de Castro MG; Hansel DE; Zhou M; Vankalakunti M; Salles PG; Cabrera RA; Gown AM; Amin MB
Am J Surg Pathol; 2012 Sep; 36(9):1265-78. PubMed ID: 22895263
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
11. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association.
Shiraishi T; Nakamura T; Ukimura O;
Int J Urol; 2018 Aug; 25(8):730-736. PubMed ID: 30016829
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma in children: experience of a single center.
Varan A; Akyuz C; Sari N; Buyukpamukçu N; Cağlar M; Buyukpamukçu M
Nephron Clin Pract; 2007; 105(2):c58-61. PubMed ID: 17135769
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients.
Naito S; Yamamoto N; Takayama T; Muramoto M; Shinohara N; Nishiyama K; Takahashi A; Maruyama R; Saika T; Hoshi S; Nagao K; Yamamoto S; Sugimura I; Uemura H; Koga S; Takahashi M; Ito F; Ozono S; Terachi T; Naito S; Tomita Y
Eur Urol; 2010 Feb; 57(2):317-25. PubMed ID: 19136199
[TBL] [Abstract][Full Text] [Related]
15. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
[TBL] [Abstract][Full Text] [Related]
17. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
18. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
Capitanio U; Cloutier V; Zini L; Isbarn H; Jeldres C; Shariat SF; Perrotte P; Antebi E; Patard JJ; Montorsi F; Karakiewicz PI
BJU Int; 2009 Jun; 103(11):1496-500. PubMed ID: 19076149
[TBL] [Abstract][Full Text] [Related]
19. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
20. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]